About us

The Subthreshold Ophthalmic Laser Society (SOLS) was established to facilitate discussion between specialist and professionals in this industry, to encourage research opportunities, innovative collaborations and knowledge and skill exchange and to be up to date in any advances in the field and its management.

 

Our mission

To promote and encourage the exchange of information through education and collaborative research.

To raise public awareness and improve standardized protocols for treatment based on consensus from global key opinion leaders.

Our vision

To encourage and support subthreshold laser research and enable the broadcasting of its results

To promote contributions to the medical and scientific research

To provide a platform for education and engagement

To promote subthreshold laser achievements worldwide

To improve best practices

To disseminate high quality subthreshold laser information to patients and public

To supporting research projects designed to foster the development and knowledge and skill exchange in medical and surgical applications linked to the technology.

To support regional, national, and international networking of laser and retinal health care professionals.

To provide an infrastructure and platform to coordinate collaboration and exchange by those interested in retinal imaging.

 
Welcome to the Subthreshold Ophthalmic Laser Society Website

"

SOLS is a new laser society to support the clinical uses of subthreshold lasers in ophthalmology. We are planning to develop best practices for different laser machines in different indications, to encourage data sharing in identifying knowledge gaps, and to design and perform new clinical trials.

President of SOLS
 

Board of directors


Dr Lihteh Wu

President, Costa Rica


Dr Alejandro Filloy Rius

Vice President , Spain


Dr Jay Chhablani

Hon. Secretary, USA


Dr Kenneth Fong

Hon. Treasurer, Malaysia


Dr Anand 
Rajendran

Assistant Hon. Secretary, India


Dr Stela Vujosevic

Assistant Hon. Treasurer, Italy

Executive committee

  • Dr Victor Chong, USA
  • Dr Barbara Parolini, Italy
  • Dr Christine Kiire, United Kingdom
  • Dr Emil Sjahreza, Indonesia
  • Dr Fang Lu, China
  • Dr Francisco Rodriguez, Republic of Colombia
  • Dr Gus Gazzard, United Kingdom
  • Dr Jans Fromow Guerra, Mexico
  • Dr José Antonio Roca Fernández, Perú
  • Dr Liu Xiao Ling, China
  • Dr Maciej Gawecki, Poland
  • Dr Marten Brelen, Hong Kong
  • Dr Zhang Xinyuan, China